Oncogene, 1476-5594

Journal

More filtering options
  1. 2020
  2. 2019
  3. Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality

    Szmyd, R., Niska-Blakie, J., Diril, M. K., Renck Nunes, P., Tzelepis, K., Lacroix, A., van Hul, N., Deng, L-W., Matos, J., Dreesen, O., Bisteau, X. & Philipp Kaldis, 2019 Feb, In : Oncogene. 38, 7, p. 998-1018

    Research output: Contribution to journalArticle

  4. ALK positively regulates MYCN activity through repression of HBP1 expression

    Claeys, S., Denecker, G., Durinck, K., Decaesteker, B., Mus, L. M., Loontiens, S., Vanhauwaert, S., Althoff, K., Wigerup, C., Bexell, D., Dolman, E., Henrich, K. O., Wehrmann, L., Westerhout, E. M., Demoulin, J. B., Kumps, C., Van Maerken, T., Laureys, G., Van Neste, C., De Wilde, B. & 8 others, De Wever, O., Westermann, F., Versteeg, R., Molenaar, J. J., Sven Påhlman, Schulte, J. H., De Preter, K. & Speleman, F., 2019, In : Oncogene. 38, 15, p. 2690-2705

    Research output: Contribution to journalArticle

  5. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression

    Yuan, X., Mu, N., Wang, N., Strååt, K., Sofiadis, A., Guo, Y., Stenman, A., Li, K., Cheng, G., Zhang, L., Kong, F., Lars Ekblad, Johan Wennerberg, Nilsson, I. L., Juhlin, C. C., Larsson, C. & Xu, D., 2019, In : Oncogene. 38, 7, p. 965-979

    Research output: Contribution to journalArticle

  6. Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion

    Brix, D. M., Tvingsholm, S. A., Hansen, M. B., Clemmensen, K. B., Ohman, T., Valentina Siino, Lambrughi, M., Hansen, K., Puustinen, P., Gromova, I., Peter James, Papaleo, E., Varjosalo, M., Moreira, J., Jäättelä, M. & Kallunki, T., 2019, In : Oncogene. 38, 17, p. 3170-3184

    Research output: Contribution to journalArticle

  7. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor

    Sarwar, M., Syed Khaja, A. S., Aleskandarany, M., Karlsson, R., Althobiti, M., Ødum, N., Mongan, N. P., Dizeyi, N., Johnson, H., Green, A. R., Ellis, I. O., Rakha, E. A. & Persson, J. L., 2019, In : Oncogene. 38, 3, p. 375-389 15 p.

    Research output: Contribution to journalArticle

  8. 2018
  9. Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma

    Li, T., Deng, Y., Shi, Y., Tian, R., Chen, Y., Zou, L., Julhash U. Kazi, Lars Rönnstrand, Feng, B., Chan, S. O., Chan, W. Y., Jianmin Sun & Zhao, H., 2018 Nov, In : Oncogene. 37, 47, p. 6180-6194

    Research output: Contribution to journalArticle

  10. 2017
  11. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment

    A. Ugale, P. Säwén, M. Dudenhöffer-Pfeifer, M. Wahlestedt, Norddahl, G. L. & D. Bryder, 2017, In : Oncogene. 36, p. 3207-3212

    Research output: Contribution to journalArticle

  12. 2016
  13. Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML

    O Lindblad, Cordero, E., Puissant, A., Macaulay, L., Ramos, A., Kabir, N. N., J Sun, J Vallon-Christersson, Haraldsson, K., Hemann, M. T., Åke Borg, F Levander, Stegmaier, K., K Pietras, L Rönnstrand & J U Kazi, 2016 Sep 29, In : Oncogene. 35, 39, p. 5119-5131 13 p.

    Research output: Contribution to journalArticle

  14. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer

    E Englund, Bartoschek, M., Reitsma, B., Jacobsson, L., Escudero-Esparza, A., Orimo, A., K Leandersson, C Hagerling, A Aspberg, P Storm, Okroj, M., H Mulder, K Jirström, K Pietras & A M Blom, 2016, In : Oncogene. 35, 43, p. 5585-5596 12 p.

    Research output: Contribution to journalArticle

  15. 2015
  16. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.

    Kobayashi, T., Masoumi, K. & Ramin Massoumi, 2015, In : Oncogene. 34, 17, p. 2251-2260

    Research output: Contribution to journalArticle

  17. MEN1 tumorigenesis in the pituitary and pancreatic islet requires CDK4 but not Cdk2

    Gillam, M. P., Nimbalkar, D., Sun, L., Christov, K., Ray, D., P. Kaldis, Liu, X. & Kiyokawa, H., 2015, In : Oncogene. 34, 7, p. 932-938

    Research output: Contribution to journalArticle

  18. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    Busch, S., Acar, A., Magnusson, Y., Gregersson, P., Lisa Rydén & Landberg, G., 2015, In : Oncogene. 34, 1, p. 27-38

    Research output: Contribution to journalArticle

  19. 2014
  20. 2013
  21. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.

    Ahlqvist, K., Saamarthy, K., Syed Khaja, A. S., Anders Bjartell & Ramin Massoumi, 2013, In : Oncogene. 32, 12, p. 1601-1608

    Research output: Contribution to journalArticle

  22. MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer

    Johansson, J., Berg, T., Kurzejamska, E., Pang, M-F., Tabor, V., Jansson, M., Roswall, P., Kristian Pietras, Sund, M., Religa, P. & Fuxe, J., 2013, In : Oncogene. 32, 50, p. 5614-5624

    Research output: Contribution to journalArticle

  23. 2012
  24. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

    Santo, E. E., Ebus, M. E., Koster, J., Schulte, J. H., Lakeman, A., van Sluis, P., Vermeulen, J., David Gisselsson Nord, Ingrid Øra, Lindner, S., Buckley, P. G., Stallings, R. L., Vandesompele, J., Eggert, A., Caron, H. N., Versteeg, R. & Molenaar, J. J., 2012, In : Oncogene. 31, 12, p. 1571-1581

    Research output: Contribution to journalArticle

  25. The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer

    Brennan, D. J., O'Connor, D. P., Laursen, H., McGee, S. F., McCarthy, S., Zagozdzon, R., Rexhepaj, E., Culhane, A. C., Martin, F. M., Duffy, M. J., Landberg, G., Lisa Rydén, Hewitt, S. M., Kuhar, M. J., Bernards, R., Millikan, R. C., Crown, J. P., Karin Jirström & Gallagher, W. M., 2012, In : Oncogene. 31, 30, p. 3483-3494

    Research output: Contribution to journalArticle

  26. 2011
  27. Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.

    Petter Storm, Sonja Aits, Puthia, M. K., Urbano, A., Northen, T., Powers, S., Bowen, B., Chao, Y., Reindl, W., Lee, D. Y., Sullivan, N. L., Zhang, J., Trulsson, M., Yang, H., Watson, J. D. & Catharina Svanborg, 2011, In : Oncogene. 30, p. 4765-4779

    Research output: Contribution to journalArticle

  28. GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma

    Kuphal, S., Shaw-Hallgren, G., Eberl, M., Karrer, S., Aberger, F., Bosserhoff, A. K. & Ramin Massoumi, 2011, In : Oncogene. 30, 44, p. 4523-4530

    Research output: Contribution to journalArticle

  29. Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis

    Rohlin, A., Engwall, Y., Fritzell, K., Goransson, K., Bergsten, A., Einbeigi, Z., Mef Nilbert, Karlsson, P., Bjork, J. & Nordling, M., 2011, In : Oncogene. 30, 50, p. 4977-4989

    Research output: Contribution to journalArticle

  30. 2010
  31. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

    Mestdagh, P., Fredlund, E., Pattyn, F., Rihani, A., Van Maerken, T., Vermeulen, J., Kumps, C., Menten, B., De Preter, K., Schramm, A., Schulte, J., Noguera, R., Schleiermacher, G., Janoueix-Lerosey, I., Laureys, G., Powel, R., Nittner, D., Marine, J-C., Ringnér, M., Speleman, F. & 1 others, Vandesompele, J., 2010, In : Oncogene. 29, 24, p. 3583-3592

    Research output: Contribution to journalArticle

  32. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression

    Iadevaia, V., Caldarola, S., Biondini, L., Gismondi, A., Stefan Karlsson, Dianzani, I. & Loreni, F., 2010, In : Oncogene. 29, 40, p. 5490-5499

    Research output: Contribution to journalArticle

  33. 2009
  34. Mammalian cell-cycle regulation: Several cdks, numerous cyclins and diverse compensatory mechanisms

    Satyanarayana, A. & P. Kaldis, 2009 Aug 20, In : Oncogene. 28, 33, p. 2925-2939

    Research output: Contribution to journalReview article

  35. Hematopoietic stem cell ageing is uncoupled from p16(INK4A)-mediated senescence.

    Attema, J., Kees-Jan Pronk, Norddahl, G., Nygren, J. & David Bryder, 2009, In : Oncogene. 28, p. 2238-2243

    Research output: Contribution to journalArticle

  36. 2008
  37. A novel fusion 5 ' AFF3/3 ' BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma

    Impera, L., Albano, F., Lo Cunsolo, C., Funes, S., Iuzzolino, P., Laveder, F., Panagopoulos, I., Rocchi, M. & Storlazzi, C. T., 2008, In : Oncogene. 27, 47, p. 6187-6190

    Research output: Contribution to journalArticle

  38. 2007
  39. Cell-specific responses to loss of cyclin-dependent kinases

    Berthet, C. & P. Kaldis, 2007 Jul 5, In : Oncogene. 26, 31, p. 4469-4477

    Research output: Contribution to journalReview article

  40. Arsenic trioxide-induced neuroblastoma cell death is accompanied by proteolytic activation of nuclear Bax.

    Jenny Karlsson, Alexander Pietras, Beckman, S., Pettersson, H., Christer Larsson & Sven Påhlman, 2007, In : Oncogene. 26, 42, p. 6150-6159

    Research output: Contribution to journalArticle

  41. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis

    McBryan, J., Jillian Howlin, Kenny, P. A., Shioda, T. & Martin, F., 2007, In : Oncogene. 26, 44, p. 6406-6419

    Research output: Contribution to journalArticle

  42. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

    Göran B Jönsson, Dahl, C., Johan Staaf, Therese Törngren, Pär-Ola Bendahl, Markus Ringnér, Guldberg, P. & Åke Borg, 2007, In : Oncogene. 26, 32, p. 4738-4748

    Research output: Contribution to journalArticle

  43. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells

    Perks, C. M., Vernon, E. G., Ann Rosendahl, Tonge, D. & Holly, J. M. P., 2007, In : Oncogene. 26, 40, p. 5966-5972

    Research output: Contribution to journalArticle

  44. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling

    Herzig, M., Savarese, F., Novatchkova, M., Semb, H. & Christofori, G., 2007, In : Oncogene. 26, 16, p. 2290-2298

    Research output: Contribution to journalArticle

  45. 2006
  46. A gene fusion network in human neoplasia.

    Mattias Höglund, Attila Frigyesi & Felix Mitelman, 2006, In : Oncogene. 25, 18, p. 2674-2678

    Research output: Contribution to journalArticle

  47. CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis

    Jillian Howlin, McBryan, J., Napoletano, S., Lambe, T., McArdle, E., Shioda, T. & Martin, F., 2006, In : Oncogene. 25, 10, p. 1532-1542

    Research output: Contribution to journalArticle

  48. Endogenous production of leukotriene D(4) mediates autocrine survival and proliferation via CysLT(1) receptor signalling in intestinal epithelial cells.

    Paruchuri, S., Mezhybovska, M., Juhas, M. & Anita Sjölander, 2006, In : Oncogene. 25, 50, p. 6660-6665

    Research output: Contribution to journalArticle

  49. 2005
  50. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.

    Wegiel, B., Anders Bjartell, Ekberg, J., Gadaleanu, V., Brunhoff, C. & Persson, J. L., 2005, In : Oncogene. 24, 42, p. 6385-6393

    Research output: Contribution to journalArticle

  51. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter

    Cismasiu, V., Adamo, K., Gecewicz, J., Duque, J., Lin, Q. & Avram, D., 2005, In : Oncogene. 24, 45, p. 6753-6764

    Research output: Contribution to journalArticle

  52. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

    Svensson Månsson, S., Karin Jirström, Lisa Rydén, Roos, G., Emdin, S., Ostrowski, M. & Landberg, G., 2005, In : Oncogene. 24, 27, p. 4370-4379

    Research output: Contribution to journalArticle

  53. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.

    Heidenblad, M., David Lindgren, Veltman, J. A., Tord Jonson, Mahlamäki, E. H., Gorunova, L., van Kessel, A. G., Schoenmakers, E. F. P. M. & Mattias Höglund, 2005, In : Oncogene. 24, 10, p. 1794-1801

    Research output: Contribution to journalArticle

  54. The role of Smad signaling in hematopoiesis.

    Jonas Larsson & Stefan Karlsson, 2005, In : Oncogene. 24, 37, p. 5676-5692

    Research output: Contribution to journalReview article

  55. Wnt-5a has tumor suppressor activity in thyroid carcinoma

    Kremenevskaja, N., von Wasielewski, R., Rao, AS., Schofl, C., Tommy Andersson & Brabant, G., 2005, In : Oncogene. 24, 13, p. 2144-2154

    Research output: Contribution to journalArticle

  56. 2004
  57. Microarray expression profiling in melanoma reveals a BRAF mutation signature

    Pavey, S., Johansson, P., Packer, L., Taylor, J., Stark, M., Pollock, PM., Walker, GJ., Boyle, GM., Harper, U., Cozzi, SJ., Hansen, K., Yudt, L., Schmidt, C., Hersey, P., Ellem, KAO., O'Rourke, MGE., Parsons, PG., Meltzer, P., Markus Ringnér & Hayward, NK., 2004, In : Oncogene. 23, 23, p. 4060-4067

    Research output: Contribution to journalArticle

  58. Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.

    Ekberg, J., Landberg, G., Wigerup, C., Johan Richter, Wolgemuth, D. J. & Persson, J. L., 2004, In : Oncogene. 23, 56, p. 9082-9089

    Research output: Contribution to journalArticle

  59. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.

    Obad, S., Brunnström, H., Johan Vallon-Christersson, Åke Borg, Kristina Drott & Urban Gullberg, 2004, In : Oncogene. 23, 23, p. 4050-4059

    Research output: Contribution to journalArticle

  60. 2003
  61. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value

    Vandesompele, J., Edsjö, A., De Preter, K., Håkan Axelson, Speleman, F. & Sven Påhlman, 2003, In : Oncogene. 22, 3, p. 456-460

    Research output: Contribution to journalArticle

Previous 1 2 Next